RC

Robert J. Cherney

BS Bristol-Myers Squibb: 34 patents #88 of 3,969Top 3%
DP Dupont Merck Pharmaceutical: 5 patents #19 of 228Top 9%
DP Dupont Pharmaceuticals: 1 patents #101 of 197Top 55%
📍 Newtown, PA: #20 of 507 inventorsTop 4%
🗺 Pennsylvania: #1,153 of 74,527 inventorsTop 2%
Overall (All Time): #82,663 of 4,157,543Top 2%
39
Patents All Time

Issued Patents All Time

Showing 1–25 of 39 patents

Patent #TitleCo-InventorsDate
11524959 Indole and azaindole inhibitors of pad enzymes Anurag S. Srivastava, Khehyong Ngu 2022-12-13
10934286 Heterocyclic sulfones as ROR gamma modulators Qingjie Liu, T. G. Murali Dhar, Lan-Ying Qin, Lyndon A. M. Cornelius, Hai-Yun Xiao +1 more 2021-03-02
10711020 Tricyclic sulfones as RORγ modulators Jingwu Duan, T. G. Murali Dhar, David Marcoux 2020-07-14
10273259 Tricyclic sulfones as RORγ modulators Jingwu Duan, T. G. Murali Dhar, David Marcoux 2019-04-30
10214537 Bicyclic heteroaryl amine compounds Rajeev S. Bhide, Douglas G. Batt, Lyndon A. M. Cornelius, Qingjie Liu, David Marcoux +8 more 2019-02-26
10023576 Heteroaryl substituted pyrrolotriazine amine compounds as PI3K inhibitors Rajeev S. Bhide, Zheming Ruan, Lyndon A. M. Cornelius, T. G. Murali Dhar, Hua Gong +5 more 2018-07-17
9815859 Tricyclic sulfones as RORγ modulators Jingwu Duan, T. G. Murali Dhar, David Marcoux, Qing Shi, Douglas G. Batt +5 more 2017-11-14
9216972 Tricyclic heterocyclic compounds T. G. Murali Dhar, Hai-Yun Xiao, Scott Hunter Watterson, Soo S. Ko, Alaric J. Dyckman +2 more 2015-12-22
8906920 N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-A][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes Percy H. Carter 2014-12-09
8835470 Mandelamide heterocyclic compounds Yanlei Zhang 2014-09-16
8642622 Piperidinyl compound as a modulator of chemokine receptor activity John V. Duncia, Daniel S. Gardner, Joseph B. Santella, Zhongyu Wang 2014-02-04
8629282 Heterocyclic compounds as S1P1 agonists for the treatment of autoimmune and vascular diseases Zhongyu Wang 2014-01-14
8618101 N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes Percy H. Carter 2013-12-31
8383812 N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-A][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes Percy H. Carter, Victor W. Rosso, Jun Li 2013-02-26
7829571 Cyclic derivatives as modulators of chemokine receptor activity Percy H. Carter, Douglas G. Batt, John V. Duncia, Daniel S. Gardner, Soo S. Ko +2 more 2010-11-09
7776884 Cyclic derivatives as modulators of chemokine receptors activity 2010-08-17
7696205 Cyclic derivatives as modulators of chemokine receptor activity 2010-04-13
7687508 Cyclic derivatives as modulators of chemokine receptor activity Percy H. Carter, John Hynes, Soo S. Ko, Anurag S. Srivastava, Zili Xiao +1 more 2010-03-30
7671062 Modulators of chemokine receptor activity, crystalline forms and process Michael G. Yang 2010-03-02
7572813 Cyclic derivatives as modulators of chemokine receptor activity 2009-08-11
7482335 Cyclic derivatives as modulators of chemokine receptor activity Percy H. Carter, Douglas G. Batt, John V. Duncia, Daniel S. Gardner, Soo S. Ko +2 more 2009-01-27
7449493 Diamines as modulators of chemokine receptor activity Percy H. Carter 2008-11-11
7378409 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity Percy H. Carter, Douglas G. Batt, Gregory D. Brown, John V. Duncia, Daniel S. Gardner +1 more 2008-05-27
7338947 Cyclic derivatives as modulators of chemokine receptor activity Percy H. Carter, John V. Duncia, Daniel S. Gardner, Joseph B. Santella 2008-03-04
7291615 Cyclic derivatives as modulators of chemokine receptor activity 2007-11-06